Sclerosing angiomatoid nodular transformation (SANT) of the spleen: review of the literature / Nodular angiomatoide esclerosante transformación (SANT) de la bazo: revisión de la literatura

We present a sclerosing angiomatoid nodular transformation (SANT) case report in a 60 year-old-woman. SANT is an extremely rare benign disease of the spleen that it is radiologically similar to malignant tumors, and clinically difficult to differentiate from other splenic diseases. Splenectomy is both diagnostic and therapeutic in symptomatic cases. The analysis of the resected spleen is necessary to achieve the final diagnosis of SANT.(AU)

Sclerosing angiomatoid nodular transformation (SANT) of the spleen: review of the literature.

We present a sclerosing angiomatoid nodular transformation (SANT) case report in a 60 year-old-woman. SANT is an extremely rare benign disease of the spleen that it is radiologically similar to malignant tumors, and clinically difficult to differentiate from other splenic diseases. Splenectomy is both diagnostic and therapeutic in symptomatic cases. The analysis of the resected spleen is necessary to achieve the final diagnosis of SANT.

Estudio prospectivo de los factores asociados al delirium en el postoperatorio de la cirugía abdominal urgente / Prospective Study of Factors Associated With Postoperative Delirium After Urgent Abdominal Surgery

INTRODUCCIÓN: El delirium es una complicación frecuente en pacientes ancianos intervenidos de cirugía abdominal urgente. MÉTODOS: Estudio prospectivo que incluye pacientes consecutivos ≥ 65 años intervenidos de cirugía abdominal urgente entre 2017 y 2019. Se registró: edad, sexo, ASA, estado fisiológico, deterioro cognitivo, fragilidad (escala de Frail), dependencia funcional (escala de Barthel), calidad de vida (Euroqol-5D-EVA), estado nutricional (MNA-SF), diagnóstico preoperatorio, tipo de cirugía (clasificación BUPA), vía de abordaje y diagnóstico de delirium postoperatorio (Confusion Assessment Method). Se realizó un análisis univariante y multivariante para analizar la relación de estas variables con el delirium. RESULTADOS: El estudio incluye 446 pacientes con una mediana de edad de 78 años; el 63,6% eran ASA ≥ III y el 8% presentaban un deterioro cognitivo previo. El 13,2% eran frágiles y el 5,4% de los pacientes tenían un grado de dependencia grave o total. Un 13,6% desarrollaron delirium en el postoperatorio. En el análisis univariante todas las variables son estadísticamente significativas salvo el sexo, el tipo de cirugía (BUPA) y la duración. En el análisis multivariante los factores asociados fueron: la edad (p < 0,001; OR: 1,08 [IC 95%: 1,038-1,139]), el ASA (p = 0,026; OR: 3,15 [IC 95%: 1,149-8,668]), la alteración fisiológica (p < 0,001; OR: 5,8 [IC 95%: 2,176 15,457]), el diagnóstico (p = 0,006) y el deterioro cognitivo (p < 0,001; OR: 5,8 [IC 95%: 2,391-14,069]). CONCLUSIÓN: Los factores asociados al delirium son la edad, el ASA, la alteración fisiológica a su llegada a urgencias, el diagnóstico preoperatorio y el deterioro cognitivo previo

INTRODUCTION: Delirium is a frequent complication in elderly patients after urgent abdominal surgery. METHODS: Prospective study of consecutive patients aged ≥ 65 years who had undergone urgent abdominal surgery from 2017-2019. The following variables were recorded: age, sex, ASA, physiological state, cognitive impairment, frailty (FRAIL Scale), functional dependence (Barthel Scale), quality of life (Euroqol-5D-VAS), nutritional status (MNA-SF), preoperative diagnosis, type of surgery (BUPA Classification), approach and diagnosis of postoperative delirium (Confusion Assessment Method). Univariate and multivariate analyses were performed to analyze the correlation of these variables with delirium. RESULTS: The study includes 446 patients with a median age of 78 years, 63.6% were ASA ≥ III and 8% had prior cognitive impairment. 13.2% were frail and 5.4% of the patients had a severe or total degree of dependence. 13.6% developed delirium in the postoperative period. In the univariate analysis, all the variables were statistically significant except for sex, type of surgery (BUPA) and duration. In the multivariate analysis the associated factors were: age (P < .001; OR: 1,08; 95% CI: 1,038-1,139), ASA (P = .026; OR: 3.15; 95% CI: 1.149-8.668), physiological state (P < .001; OR: 5.8; 95% CI: 2.176-15.457), diagnosis (P = .006) and cognitive impairment (P < .001; OR: 5.8; 95% CI: 2.391-14.069). CONCLUSION: The factors associated with delirium are age, ASA, physiological state in the emergency room, preoperative diagnosis and prior cognitive impairment

Prospective Study of Factors Associated With Postoperative Delirium After Urgent Abdominal Surgery. / Estudio prospectivo de los factores asociados al delirium en el postoperatorio de la cirugía abdominal urgente.

INTRODUCTION: Delirium is a frequent complication in elderly patients after urgent abdominal surgery. METHODS: Prospective study of consecutive patients aged ≥65years who had undergone urgent abdominal surgery from 2017-2019. The following variables were recorded: age, sex, ASA, physiological state, cognitive impairment, frailty (FRAIL Scale), functional dependence (Barthel Scale), quality of life (Euroqol-5D-VAS), nutritional status (MNA-SF), preoperative diagnosis, type of surgery (BUPA Classification), approach and diagnosis of postoperative delirium (Confusion Assessment Method). Univariate and multivariate analyses were performed to analyze the correlation of these variables with delirium. RESULTS: The study includes 446 patients with a median age of 78years, 63.6% were ASA ≥III and 8% had prior cognitive impairment. 13.2% were frail and 5.4% of the patients had a severe or total degree of dependence. 13.6% developed delirium in the postoperative period. In the univariate analysis, all the variables were statistically significant except for sex, type of surgery (BUPA) and duration. In the multivariate analysis the associated factors were: age (P<.001; OR: 1,08; 95%CI: 1,038-1,139), ASA (P=.026; OR: 3.15; 95%CI: 1.149-8.668), physiological state (P<.001; OR: 5.8; 95%CI: 2.176-15.457), diagnosis (P=.006) and cognitive impairment (P<.001; OR: 5.8; 95%CI: 2.391-14.069). CONCLUSION: The factors associated with delirium are age, ASA, physiological state in the emergency room, preoperative diagnosis and prior cognitive impairment.

Efecto de la colocación de prótesis biliares preoperatorias en las complicaciones infecciosas de la duodenopancreatectomía cefálica / The effect of a preoperative biliary prosthesis on the infectious complications of the pancreaticoduodenectomy

Introducción: existe controversia sobre el efecto de las prótesis biliares preoperatorias (PBP) en las complicaciones de la duodenopancreatectomía (DPC). No hay recomendaciones para la profilaxis antibiótica en estos pacientes. Nuestro objetivo es estudiar la asociación de las PBP, bacteriología y el desarrollo de complicaciones después de la DP. Métodos: estudio observacional retrospectivo con 90 pacientes consecutivos sometidos a DPC entre 2015-2018. Se indicó PBP en pacientes con bilirrubina total > 12 mg/dl que no pudieron ser intervenidos en un tiempo razonable. La profilaxis antibiótica fue cefoxitina en pacientes sin PBP y tratamiento de cinco días con piperacilina-tazobactam con PBP. Se realizó sistemáticamente un cultivo de bilis. Resultados: la edad promedio fue de 69 años. Cincuenta y un pacientes tuvieron complicaciones (56%), con una mortalidad del 3%. La estancia media fue de once días. Se colocó PBP en 51 pacientes (56%). La profilaxis antibiótica fue adecuada en 62 pacientes (69%). Los gérmenes más aislados fueron E. faecium (30%), E. coli (20%) y E. faecalis (19%). Los pacientes con PBP tuvieron un porcentaje significativamente mayor de cultivos positivos (98% frente a 25%, p < 0,01), mayor número de gérmenes (2,9 frente a 0,5, p < 0,01) y sepsis perioperatoria (31% frente a 12%, p = 0,03), sin aumentar la estancia o la morbilidad global. Conclusiones: las PBP aumentan el riesgo de sepsis perioperatoria, el porcentaje de cultivos positivos y el número promedio de gérmenes aislados. El protocolo de profilaxis con cefoxitina y el tratamiento con pipercilina-tazobactan con PBP tratan adecuadamente al 69% de los pacientes. Con este protocolo, las PBP no implican un aumento de las complicaciones ni de la estancia

Introduction: there is controversy about the effect of a preoperative biliary prosthesis (PBP) on complications of pancreaticoduodenectomy (PD). There are no recommendations for antibiotic prophylaxis in these patients. The objective of the study was to analyze the association of PBP, bacteriology and the development of complications after PD. Methods: this was a retrospective observational study with 90 consecutive patients that underwent DP between 2015 and 2018. PBP was indicated in patients with total bilirubin levels > 12 mg/dl who could not be operated on within a reasonable time. Antibiotic prophylaxis with cefoxitin was administered in patients without PBP and a five-day treatment with piperacillin-tazobactam for PBP. A bile culture was systematically performed. Results: the average age of the patient cohort was 69 years. Fifty-one patients suffered complications (56%), with a mortality rate of 3%. The average hospital stay was eleven days and PBP was placed in 51 patients (56%). Antibiotic prophylaxis was adequate in 62 patients (69%). The most frequently isolated bacteria were E. faecium (30%), E. coli (20%) and E. faecalis (19%). Patients with PBP had a significantly higher percentage of positive cultures (98% vs 25%, p < 0.01), a higher number of bacteria (2.9 vs 0.5, p < 0.01) and perioperative sepsis (31% vs 12%, p = 0.03), but without an increased hospital stay or overall morbidity. Conclusions: PBPs increase the risk of perioperative sepsis, the percentage of positive cultures and the average number of isolated bacteria. The protocol of prophylaxis with cefoxitin and the administration of pipercillin-tazobactan with PBP adequately treated 69% of patients. With this protocol, PBPs do not imply an increase in complications or hospital stay

The effect of a preoperative biliary prosthesis on the infectious complications of the pancreaticoduodenectomy.

INTRODUCTION: there is controversy about the effect of a preoperative biliary prosthesis (PBP) on complications of pancreaticoduodenectomy (PD). There are no recommendations for antibiotic prophylaxis in these patients. The objective of the study was to analyze the association of PBP, bacteriology and the development of complications after PD. METHODS: this was a retrospective observational study with 90 consecutive patients that underwent DP between 2015 and 2018. PBP was indicated in patients with total bilirubin levels > 12 mg/dl who could not be operated on within a reasonable time. Antibiotic prophylaxis with cefoxitin was administered in patients without PBP and a five-day treatment with piperacillin-tazobactam for PBP. A bile culture was systematically performed. RESULTS: the average age of the patient cohort was 69 years. Fifty-one patients suffered complications (56%), with a mortality rate of 3%. The average hospital stay was eleven days and PBP was placed in 51 patients (56%). Antibiotic prophylaxis was adequate in 62 patients (69%). The most frequently isolated bacteria were E. faecium (30%), E. coli (20%) and E. faecalis (19%). Patients with PBP had a significantly higher percentage of positive cultures (98% vs 25%, p < 0.01), a higher number of bacteria (2.9 vs 0.5, p < 0.01) and perioperative sepsis (31% vs 12%, p = 0.03), but without an increased hospital stay or overall morbidity. CONCLUSIONS: PBPs increase the risk of perioperative sepsis, the percentage of positive cultures and the average number of isolated bacteria. The protocol of prophylaxis with cefoxitin and the administration of pipercillin-tazobactan with PBP adequately treated 69% of patients. With this protocol, PBPs do not imply an increase in complications or hospital stay.

Supervivencia y morbimortalidad del adenocarcinoma de páncreas tratado con duodenopancreatectomía cefálica con extirpación total del mesopáncreas / Survival, morbidity and mortality of pancreatic adenocarcinoma after pancreaticoduodenectomy with a total mesopancreas excision

Introducción: el adenocarcinoma de páncreas es la neoplasia maligna más frecuente del área periampular; con una supervivencia a cinco años, se sitúa en torno al 20%. Objetivo: el objetivo de nuestro estudio es mostrar los resultados de supervivencia y seguridad de los pacientes intervenidos mediante duodenopancreatectomía cefálica con extirpación total del mesopáncreas (ETMP). Material y métodos: estudio observacional prospectivo que incluye 114 pacientes con adenocarcinoma de páncreas, intervenidos mediante duodenopancreatectomía con ETMP entre 2008 y 2017. Se analizaron las variables demográficas, el estadio tumoral, el número de ganglios extirpados, la ratio ganglionar, la clasificación R y los factores pronósticos del intervalo libre de enfermedad y la supervivencia mediante un análisis multivariante. Resultados: presentaron complicaciones 54 (47,3%) pacientes; 22 (19,3%) se clasificaron como graves. La mortalidad fue del 4,3%. El seguimiento medio fue de 26,2 meses. Durante este periodo, 73 (64%) pacientes presentaron una recaída con un intervalo medio de 40,9 meses. El patrón de recaída fue principalmente hepático (26,3%), seguido de la recaída local (20%). La supervivencia media fue del 40,38% y la actuarial, del 26,6% a cinco años. Los factores relacionados con la recaída fueron la estadificación T3 o superior (RR 8,1 [1,1; 61]) y las resecciones R1 (RR 13,4 [2,7; 66,5]) y con la supervivencia, las resecciones R1 (RR 10,7 [2,5; 46,2]). Conclusión: la ETMP garantiza una linfadenectomía y una ratio ganglionar adecuadas según los estándares publicados. La supervivencia de los pacientes intervenidos por adenocarcinoma de páncreas en nuestro centro es del 68,4% a un año y del 26,6% a cinco años. El principal factor de recaída y de mortalidad son las resecciones R1

Introduction: pancreatic adenocarcinoma is the most common malignancy in the periampullary region, with a five-year survival rate around 20%. Objective: the goal of our study was to determine the survival and safety data of a number of patients that underwent a cephalic duodenopancreatectomy (CDP) with total mesopancreas excision (TMPE). Material and methods: a prospective observational study was performed of 114 patients with pancreatic adenocarcinoma who underwent duodenopancreatectomy and TMPE over the period 2008-2017. Demographic variables, tumor stage, number of lymph nodes excised, lymph node ratio, R classification, the prognostic factor disease-free interval and survival were all assessed in a multivariate analysis. Results: complications were reported for 54 (47.3%) patients, of which 22 (19.3%) were categorized as serious. The mortality rate was 4.3% and the mean follow-up was 26.2 months. During this period, 73 (64%) patients relapsed after a mean interval of 40.9 months. The relapse pattern was mainly hepatic (26.3%), followed by local relapse (20%). Mean survival was 40.38 and actuarial survival was 26.6% at five years. Relapse-related factors included stage T3 or higher (RR 8.1 [1.1-61]) and an R1 resection (RR 13.4 [2.7-66.5]) and survival-related factors included an R1 resection (RR 10.7 [2.5-46.2]). Conclusion: TMPE ensures an adequate lymphadenectomy and lymph node ratio according to reported standards. The survival of patients that have undergone surgery for pancreatic adenocarcinoma in our institution is 68.4% at one year and 26.6% at five years. An R1 resection is the primary factor for both relapse and survival

Survival, morbidity and mortality of pancreatic adenocarcinoma after pancreaticoduodenectomy with a total mesopancreas excision.

INTRODUCTION: pancreatic adenocarcinoma is the most common malignancy in the periampullary region, with a five-year survival rate around 20%. OBJECTIVE: the goal of our study was to determine the survival and safety data of a number of patients that underwent a cephalic duodenopancreatectomy (CDP) with total mesopancreas excision (TMPE). MATERIAL AND METHODS: a prospective observational study was performed of 114 patients with pancreatic adenocarcinoma who underwent duodenopancreatectomy and TMPE over the period 2008-2017. Demographic variables, tumor stage, number of lymph nodes excised, lymph node ratio, R classification, the prognostic factor disease-free interval and survival were all assessed in a multivariate analysis. RESULTS: complications were reported for 54 (47.3%) patients, of which 22 (19.3%) were categorized as serious. The mortality rate was 4.3% and the mean follow-up was 26.2 months. During this period, 73 (64%) patients relapsed after a mean interval of 40.9 months. The relapse pattern was mainly hepatic (26.3%), followed by local relapse (20%). Mean survival was 40.38 and actuarial survival was 26.6% at five years. Relapse-related factors included stage T3 or higher (RR 8.1 [1.1-61]) and an R1 resection (RR 13.4 [2.7-66.5]) and survival-related factors included an R1 resection (RR 10.7 [2.5-46.2]). CONCLUSION: TMPE ensures an adequate lymphadenectomy and lymph node ratio according to reported standards. The survival of patients that have undergone surgery for pancreatic adenocarcinoma in our institution is 68.4% at one year and 26.6% at five years. An R1 resection is the primary factor for both relapse and survival.

Neoplasia papilar mucinosa intraductal de conducto principal en un paciente con páncreas divisum / Intraductal papillary mucinous neoplasm of the main duct in a patient with pancreas divisum

No disponible

Intraductal papillary mucinous neoplasm of the main duct in a patient with pancreas divisum.

Pancreas divisum is a congenital anomaly present in 5-10% of the population and is usually asymptomatic. Pancreatic intraductal papillary mucinous neoplasms (IPMN) are mucinous cystic tumors that have malignant potential and are classified according to their location as IPMN of the main duct, branch duct or mixed type. Larger lesions and those originating in the main duct have an increased risk of malignancy. The real incidence is unknown as most lesions are asymptomatic.

Delayed gastric emptying following pancreatoduodenectomy: a Roux-en-Y gastrojejunostomy vs Billroth II gastrojejunostomy randomized study

Introduction: delayed gastric emptying (DGE) is the most common complication after pancreaticoduodenectomy (PD) and it occurs in 50% of cases. Objectives: the endpoint was to determine if there were any differences in the incidence of DGE between Roux-en-Y gastrojejunostomy (ReY) and Billroth II gastrojejunostomy (BII) in PD with pancreaticogastrostomy (PG). Methods: this was a case-control prospective randomized study of all PD cases between 2013 and 2016. Sixty-four patients were included, 32 in each group. An intention-to-treat statistical analysis was performed. Results: no significant differences were found with regard to morbidity and mortality or hospital stay. DGE was present in 25% of the patients in the BII group in comparison to 15.6% in the ReY group, which was not statistically significant (p = 0.35). There was a higher percentage of patients with primary DGE in the BII group, 12.5% versus 6.2%, but this was not statistically significant (p = 0.53). No difference in DGE severity was observed. Male gender (OR 8.38 [1.1; 129]), abdominal complications (OR 15 [1.7; 396.9]), pre-operative malnutrition (OR 99.7 [3.3, 11,126]) and hemorrhage (OR 9.4 [1.37, 107.94]) were the main risk factors for DGE according to the multivariate analysis. Conclusions: there were no significant differences in the incidence or severity of DGE between BII or ReY after PD with PG

No disponible

Delayed gastric emptying following pancreatoduodenectomy: a Roux-en-Y gastrojejunostomy vs Billroth II gastrojejunostomy randomized study.

INTRODUCTION: delayed gastric emptying (DGE) is the most common complication after pancreaticoduodenectomy (PD) and it occurs in 50% of cases. OBJECTIVES: the endpoint was to determine if there were any differences in the incidence of DGE between Roux-en-Y gastrojejunostomy (ReY) and Billroth II gastrojejunostomy (BII) in PD with pancreaticogastrostomy (PG). METHODS: this was a case-control prospective randomized study of all PD cases between 2013 and 2016. Sixty-four patients were included, 32 in each group. An intention-to-treat statistical analysis was performed. RESULTS: no significant differences were found with regard to morbidity and mortality or hospital stay. DGE was present in 25% of the patients in the BII group in comparison to 15.6% in the ReY group, which was not statistically significant (p = 0.35). There was a higher percentage of patients with primary DGE in the BII group, 12.5% versus 6.2%, but this was not statistically significant (p = 0.53). No difference in DGE severity was observed. Male gender (OR 8.38 [1.1; 129]), abdominal complications (OR 15 [1.7; 396.9]), pre-operative malnutrition (OR 99.7 [3.3, 11,126]) and hemorrhage (OR 9.4 [1.37, 107.94]) were the main risk factors for DGE according to the multivariate analysis. CONCLUSIONS: there were no significant differences in the incidence or severity of DGE between BII or ReY after PD with PG.

Nuestra experiencia en el tratamiento del PEComa hepático / Our experience in the surgical treatment of liver PEComa

No disponible

Síndrome del muñón cístico como causa de síndrome poscolecistectomía / Cystic duct remnant syndrome as a cause of post-cholecystectomy syndrome

No disponible

Quality standards in 480 pancreatic resections: a prospective observational study.

Pancreatic resection is a standard procedure for the treatment of periampullary tumors. Morbidity and mortality are high, and quality standards are scarce in our setting. International classifications of complications (Clavien-Dindo) and those specific for pancreatectomies (ISGPS) allow adequate case comparisons. The goals of our work are to describe the morbidity and mortality of 480 pancreatectomies using the international classifications ISGPS and Clavien-Dindo to help establish a quality standard in our setting and to compare the results of CPD with reconstruction by pancreaticogastrostomy (1,55) versus 177 pancreaticojejunostomy). We report 480 resections including 337 duodenopancreatectomies, 116 distal pancreatectomies, 11 total pancreatectomies, 10 central pancreatectomies, and 6 enucleations. Results for duodenopancreatectomy include: 62 % morbidity (Clavien > or = III 25.9 %), 12.3 % reinterventions, and 3.3 % overall mortality. For reconstruction by pancreaticojejunostomy: 71.2 % morbidity (Clavien > or = III 34.4 %), 17.5 % reinterventions, and 3.3 % mortality. For reconstruction by pancreaticogastrostomy: 51 % morbidity (Clavien > or = III 15.4%), 6.4 % reinterventions, and 3.2 % mortality. Differences are significant except for mortality. We conclude that our series meets quality criteria as compared to other groups. Reconstruction with pancreaticogastrostomy significantly reduces complication number and severity, as well as pancreatic fistula and reintervention rates.

Estándares de calidad en 480 resecciones pancreáticas: estudio prospectivo observacional / Quality standards in 480 pancreatic resections: a prospective observational study

INTRODUCCIÓN: la resección pancreática es un procedimiento estándar para el tratamiento de los tumores periampulares. La morbimortalidad es elevada y los estándares de calidad en nuestro medio son escasos. Las clasificaciones internacionales de las complicaciones Clavien-Dindo y las específicas de las pancreatectomías (ISGPS) permiten una adecuada comparación de casuísticas. OBJETIVOS: los objetivos de nuestro trabajo son describir la morbimortalidad de 480 pancreatectomías utilizando las clasificaciones internacionales ISGPS y Clavien-Dindo para contribuir al establecimiento de un estándar de calidad en nuestro medio, y comparar los resultados de la DPC con reconstrucción mediante pancreaticogastrostomía (1.55) frente a la pancreaticoyeyunostomía (177). MÉTODOS: presentamos 480 resecciones que incluyen 337 duodenopancreatectomías, 116 pancreatectomías distales, 11 pancreatectomías totales, 10 pancreatectomías centrales y 6 enucleaciones. RESULTADOS: los resultados en la duodenopancreatectomía son: 62 % de morbilidad (Clavien ≥ III 25,9 %), 12,3 % de reintervenciones y 3,3 % de mortalidad global. En las reconstrucción con pancreaticoyeyunostomía: 71,2 % de morbilidad (Clavien ≥ III 34,4 %), 17,5 % de reintervenciones y 3,3 % de mortalidad. En la reconstrucción con pancreaticogastrostomía: 51 % de morbilidad (Clavien ≥ III 15,4 %), 6,4 % de reintervenciones y 3,2 % de mortalidad, las diferencias son significativas, excepto en la mortalidad. CONCLUSIONES: concluimos que nuestra serie cumple criterios de calidad en comparación con la experiencia de otros grupos. La reconstrucción con pancreaticogastrostomía disminuye significativamente el número de complicaciones, su gravedad, la tasa de fístula pancreática y las reintervenciones

BACKGROUND: Pancreatic resection is a standard procedure for the treatment of periampullary tumors. Morbidity and mortality are high, and quality standards are scarce in our setting. International classifications of complications (Clavien-Dindo) and those specific for pancreatectomies (ISGPS) allow adequate case comparisons. OBJECTIVES: The goals of our work are to describe the morbidity and mortality of 480 pancreatectomies using the international classifications ISGPS and Clavien-Dindo to help establish a quality standard in our setting and to compare the results of CPD with reconstruction by pancreaticogastrostomy (1,559 versus 177 pancreaticojejunostomy). METHODS: We report 480 resections including 337 duodenopancreatectomies, 116 distal pancreatectomies, 11 total pancreatectomies, 10 central pancreatectomies, and 6 enucleations. RESULTS: Results for duodenopancreatectomy include: 62 % morbidity (Clavien ≥ III 25.9 %), 12.3 % reinterventions, and 3.3 % overall mortality. For reconstruction by pancreaticojejunostomy: 71.2 % morbidity (Clavien ≥ III 34.4 %), 17.5 % reinterventions, and 3.3 % mortality. For reconstruction by pancreaticogastrostomy: 51 % morbidity (Clavien ≥ III 15.4%), 6.4 % reinterventions, and 3.2 % mortality. Differences are significant except for mortality. CONCLUSIONS: We conclude that our series meets quality criteria as compared to other groups. Reconstruction with pancreaticogastrostomy significantly reduces complication number and severity, as well as pancreatic fistula and reintervention rates